Vir Biotechnology Inc (VIR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -168,911 | -298,665 | -193,016 | -108,407 | -77,240 |
| Depreciation Amortization | 1,811 | 7,822 | 5,987 | 3,491 | 1,868 |
| Income taxes - deferred | N/A | -52 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,317 | -790 | 1,041 | -1,342 | 12,944 |
| Other Working Capital | 16,135 | 29,522 | 3,551 | -2,639 | -786 |
| Other Operating Activity | 62,753 | 71,222 | 73,548 | 49,849 | 14,805 |
| Operating Cash Flow | $-89,529 | $-190,941 | $-108,889 | $-59,048 | $-48,409 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 88,201 | -3,493 | -66,636 | 117,269 | 105,341 |
| PPE Investments | -667 | -6,369 | -3,939 | -2,465 | -1,122 |
| Investing Cash Flow | $87,534 | $-9,862 | $-70,575 | $114,804 | $104,219 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -62 | -250 | -173 | -115 | -58 |
| Common Stock Issued | 87,565 | 533,972 | 533,453 | 209,087 | 143 |
| Other Financing Activity | 0 | -4,248 | -3,547 | -3,547 | 0 |
| Financing Cash Flow | $87,503 | $529,474 | $529,733 | $205,425 | $85 |
| Beginning Cash Position | 451,487 | 122,816 | 122,816 | 122,816 | 122,816 |
| End Cash Position | 536,995 | 451,487 | 473,085 | 383,997 | 178,711 |
| Net Cash Flow | $85,508 | $328,671 | $350,269 | $261,181 | $55,895 |
| Free Cash Flow | |||||
| Operating Cash Flow | -89,529 | -190,941 | -108,889 | -59,048 | -48,409 |
| Capital Expenditure | -667 | -6,549 | -4,119 | -2,645 | -1,302 |
| Free Cash Flow | -90,196 | -197,490 | -113,008 | -61,693 | -49,711 |